Clinical Trial Update: Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a nano drug interventional therapy guided by digital subtraction angiography for hepatocellular carcinoma has completed. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Nano Drug Interventional Therapy using Digital Subtraction Angiography (DSA)

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Liver Cancer | Phase 1, Phase 2 | Status: COMPLETED